323 related articles for article (PubMed ID: 16247481)
1. SWI/SNF complex is essential for NRSF-mediated suppression of neuronal genes in human nonsmall cell lung carcinoma cell lines.
Watanabe H; Mizutani T; Haraguchi T; Yamamichi N; Minoguchi S; Yamamichi-Nishina M; Mori N; Kameda T; Sugiyama T; Iba H
Oncogene; 2006 Jan; 25(3):470-9. PubMed ID: 16247481
[TBL] [Abstract][Full Text] [Related]
2. SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation.
Banine F; Bartlett C; Gunawardena R; Muchardt C; Yaniv M; Knudsen ES; Weissman BE; Sherman LS
Cancer Res; 2005 May; 65(9):3542-7. PubMed ID: 15867346
[TBL] [Abstract][Full Text] [Related]
3. Mammalian chromatin remodeling complex SWI/SNF is essential for enhanced expression of the albumin gene during liver development.
Inayoshi Y; Miyake K; Machida Y; Kaneoka H; Terajima M; Dohda T; Takahashi M; Iijima S
J Biochem; 2006 Feb; 139(2):177-88. PubMed ID: 16452305
[TBL] [Abstract][Full Text] [Related]
4. SWI/SNF chromatin remodeling complex is critical for the expression of microphthalmia-associated transcription factor in melanoma cells.
Vachtenheim J; Ondrusová L; Borovanský J
Biochem Biophys Res Commun; 2010 Feb; 392(3):454-9. PubMed ID: 20083088
[TBL] [Abstract][Full Text] [Related]
5. Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis.
Reisman DN; Sciarrotta J; Wang W; Funkhouser WK; Weissman BE
Cancer Res; 2003 Feb; 63(3):560-6. PubMed ID: 12566296
[TBL] [Abstract][Full Text] [Related]
6. The reversible epigenetic silencing of BRM: implications for clinical targeted therapy.
Glaros S; Cirrincione GM; Muchardt C; Kleer CG; Michael CW; Reisman D
Oncogene; 2007 Oct; 26(49):7058-66. PubMed ID: 17546055
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.
Sun A; Tawfik O; Gayed B; Thrasher JB; Hoestje S; Li C; Li B
Prostate; 2007 Feb; 67(2):203-13. PubMed ID: 17075831
[TBL] [Abstract][Full Text] [Related]
8. Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression.
Reisman DN; Strobeck MW; Betz BL; Sciariotta J; Funkhouser W; Murchardt C; Yaniv M; Sherman LS; Knudsen ES; Weissman BE
Oncogene; 2002 Feb; 21(8):1196-207. PubMed ID: 11850839
[TBL] [Abstract][Full Text] [Related]
9. Brm transactivates the telomerase reverse transcriptase (TERT) gene and modulates the splicing patterns of its transcripts in concert with p54(nrb).
Ito T; Watanabe H; Yamamichi N; Kondo S; Tando T; Haraguchi T; Mizutani T; Sakurai K; Fujita S; Izumi T; Isobe T; Iba H
Biochem J; 2008 Apr; 411(1):201-9. PubMed ID: 18042045
[TBL] [Abstract][Full Text] [Related]
10. When the SWI/SNF complex remodels...the cell cycle.
Muchardt C; Yaniv M
Oncogene; 2001 May; 20(24):3067-75. PubMed ID: 11420722
[TBL] [Abstract][Full Text] [Related]
11. N-terminally truncated BAF57 isoforms contribute to the diversity of SWI/SNF complexes in neurons.
Kazantseva A; Sepp M; Kazantseva J; Sadam H; Pruunsild P; Timmusk T; Neuman T; Palm K
J Neurochem; 2009 May; 109(3):807-18. PubMed ID: 19245665
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs miR-199a-5p and -3p target the Brm subunit of SWI/SNF to generate a double-negative feedback loop in a variety of human cancers.
Sakurai K; Furukawa C; Haraguchi T; Inada K; Shiogama K; Tagawa T; Fujita S; Ueno Y; Ogata A; Ito M; Tsutsumi Y; Iba H
Cancer Res; 2011 Mar; 71(5):1680-9. PubMed ID: 21189327
[TBL] [Abstract][Full Text] [Related]
13. Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines.
Medina PP; Romero OA; Kohno T; Montuenga LM; Pio R; Yokota J; Sanchez-Cespedes M
Hum Mutat; 2008 May; 29(5):617-22. PubMed ID: 18386774
[TBL] [Abstract][Full Text] [Related]
14. The Drosophila Brahma (SWI/SNF) chromatin remodeling complex exhibits cell-type specific activation and repression functions.
Marenda DR; Zraly CB; Dingwall AK
Dev Biol; 2004 Mar; 267(2):279-93. PubMed ID: 15013794
[TBL] [Abstract][Full Text] [Related]
15. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.
Medina PP; Carretero J; Fraga MF; Esteller M; Sidransky D; Sanchez-Cespedes M
Genes Chromosomes Cancer; 2004 Oct; 41(2):170-7. PubMed ID: 15287030
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of the neuron restrictive silencer factor permits transcription of glycine receptor alpha1 subunit in small-cell lung cancer cells.
Gurrola-Diaz C; Lacroix J; Dihlmann S; Becker CM; von Knebel Doeberitz M
Oncogene; 2003 Aug; 22(36):5636-45. PubMed ID: 12944912
[TBL] [Abstract][Full Text] [Related]
17. Repression of GR-mediated expression of the tryptophan oxygenase gene by the SWI/SNF complex during liver development.
Inayoshi Y; Kaneoka H; Machida Y; Terajima M; Dohda T; Miyake K; Iijima S
J Biochem; 2005 Oct; 138(4):457-65. PubMed ID: 16272140
[TBL] [Abstract][Full Text] [Related]
18. A splice variant of the neuron-restrictive silencer factor repressor is expressed in small cell lung cancer: a potential role in derepression of neuroendocrine genes and a useful clinical marker.
Coulson JM; Edgson JL; Woll PJ; Quinn JP
Cancer Res; 2000 Apr; 60(7):1840-4. PubMed ID: 10766169
[TBL] [Abstract][Full Text] [Related]
19. SMARCA2 and other genome-wide supported schizophrenia-associated genes: regulation by REST/NRSF, network organization and primate-specific evolution.
Loe-Mie Y; Lepagnol-Bestel AM; Maussion G; Doron-Faigenboim A; Imbeaud S; Delacroix H; Aggerbeck L; Pupko T; Gorwood P; Simonneau M; Moalic JM
Hum Mol Genet; 2010 Jul; 19(14):2841-57. PubMed ID: 20457675
[TBL] [Abstract][Full Text] [Related]
20. BRG1 loss in MiaPaCa2 cells induces an altered cellular morphology and disruption in the organization of the actin cytoskeleton.
Rosson GB; Bartlett C; Reed W; Weissman BE
J Cell Physiol; 2005 Nov; 205(2):286-94. PubMed ID: 15887247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
